![Remarkable Improvement Rate Reported in Patients Who Received SAINT, an Experimental Non-Invasive Brain-Stimulation Treatment for Resistant Depression](/sites/default/files/styles/large/public/field/image/scientificprogress-1440_1.jpg?itok=5qcL9e7n)
With the help of BBRF grants, researchers are testing a new treatment for people with major depression who have not responded to existing treatments. The first report of its effectiveness is very…
Read More
![Opioids, at Very Low Doses, May Provide a New Way to Treat Resistant Depression Opioids, at Very Low Doses, May Provide a New Way to Treat Resistant Depression](/sites/default/files/styles/large/public/field/image/ketamine-1440_0.png?itok=pfkGYHvv)
One of the most promising new therapy ideas for brain and behavior disorders may at first seem improbable: using opioid-based medicines to reduce the symptoms of depression. Isn’t our society in the…
Read More
![Pioneering TMS Therapy for Depression Pioneering TMS Therapy for Depression](/sites/default/files/styles/large/public/field/image/brainnetworkrenderonwhitebackground-1440_2.jpg?itok=83d40PQm)
Luck, Hard Work...and Crucially Timed BBRF Grants
There is a moment in the career of Mark S. George, M.D., that he thinks of as lucky. It changed the course of his life and—though he could not have…
Read More
![What Is Transcranial Magnetic Stimulation (TMS) Treatment and How Well does It Work?](/sites/default/files/styles/large/public/field/image/neuroncellsnetworkconcept-1440-short_0.jpg?itok=X3htBAnL)
“The basics of TMS treatment are simple,” says Dr. Mark George, who performed research for more than a decade that led to its approval for treatment-resistant depression in 2008. “You have a patient…
Read More
![Advisory Panel Recommends FDA Approval of Esketamine , with New Mechanism to Treat Resistant Depression & Suicidal Thinking](/sites/default/files/styles/large/public/field/image/neuronsinthebrainonlightbackground-1440_3.jpg?itok=M4VpOD9E)
On February 12th, an FDA advisory panel recommended overwhelmingly that the agency approve a drug called esketamine for the rapid relief of depression in patients who have not been helped by existing…
Read More